Vaerlose, Denmark

Holger C Hansen


Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 140(Granted Patents)


Location History:

  • Ballerup, DK (1989 - 1990)
  • V rlose, DK (1991 - 1994)
  • V.ae butted.rl.o slashed.se, DK (1998 - 1999)
  • Værløse, DK (2001)
  • Væløse, DK (2010)
  • Vaerlose, DK (1989 - 2011)

Company Filing History:


Years Active: 1989-2011

Loading Chart...
24 patents (USPTO):Explore Patents

Title: Holger C Hansen: Innovator in the Field of Pharmaceuticals

Introduction

Holger C Hansen, based in Vaerlose, Denmark, is a prominent inventor known for his significant contributions to the pharmaceutical industry, boasting an impressive portfolio of 24 patents. His work primarily focuses on innovative compounds aimed at treating obesity and diabetes, positioning him as a key player in this critical area of health.

Latest Patents

Among his latest patents, Hansen has developed novel compounds such as "2-(2-hydroxyphenyl) benzothiadiazines" and "2-(2-hydroxyphenyl) benzimidazoles," both of which are recognized for their role as chemical uncouplers in metabolic treatment. These compounds are not only useful in the treatment of obesity and diabetes but also serve to prevent various diseases and conditions associated with these health issues, demonstrating Hansen's commitment to advancing therapeutic options.

Career Highlights

Holger C Hansen's career includes notable tenures at reputable companies, including Novo Nordisk A/S and A/S Ferrosan. His experience in these organizations has facilitated the development of his groundbreaking inventions, allowing him to leverage resources and collaborate with other experts in the field.

Collaborations

Throughout his career, Hansen has worked alongside esteemed colleagues such as Frank Watjen and Flemming E Nielsen. Their collaborative efforts have contributed to the successful development of innovative pharmaceutical solutions, underscoring the importance of teamwork in driving scientific discovery.

Conclusion

In summary, Holger C Hansen stands out as a noteworthy inventor within the pharmaceutical domain, with a focus on creating impactful treatments for obesity and diabetes. His extensive patent portfolio and collaboration with leading companies and professionals further highlight his influence and dedication to improving global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…